Pescovitz Ora H. 4

What Happened
Ora H. Pescovitz, a director of MBX Biosciences, was granted an award for 12,500 shares on 2026-06-04. The shares were reported as acquired at $0.00 per share (total reported value $0) and are a derivative award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-04; Form 4 filed 2026-06-05 (timely filing).
• Type: Award/other acquisition (code "A") reported as a derivative; price reported $0.00; total reported value $0.
• Vesting: The grant vests in full on the earlier of the one‑year anniversary of the grant date or the date of the next annual meeting of stockholders, subject to the director’s continued service (footnote F1).
• Shares owned after the transaction: not specified in the provided filing excerpt.
• No 10b5-1 plan, tax withholding, or sale noted in the disclosure.

Context: This is a standard director compensation award (likely restricted stock or RSU-like), not a purchase or sale. Such awards are common for non-employee directors and reflect compensation rather than an immediate directional trade in the market.